Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation

PURPOSE: Plasmablastic lymphoma (PBL) is a rare and aggressive B-cell malignancy with a heterogenous clinical and prognostic spectrum, determined by multiple factors, including age, HIV- and MYC-status. While there exist several validated scoring systems for diffuse large B-cell lymphoma, which inco...

Descripción completa

Detalles Bibliográficos
Autores principales: Hertel, Nadine, Merz, Hartmut, Bernd, Heinz-Wolfram, Bernard, Veronica, Künstner, Axel, Busch, Hauke, von Bubnoff, Nikolas, Feller, Alfred C., Witte, Hanno M., Gebauer, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397630/
https://www.ncbi.nlm.nih.gov/pubmed/33660007
http://dx.doi.org/10.1007/s00432-021-03580-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397630/
https://www.ncbi.nlm.nih.gov/pubmed/33660007
http://dx.doi.org/10.1007/s00432-021-03580-z

Ejemplares similares